4//SEC Filing
Easom Eric 4
Accession 0000899243-22-035472
CIK 0001880438other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 8:33 PM ET
Size
11.5 KB
Accession
0000899243-22-035472
Insider Transaction Report
Form 4
Easom Eric
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2022-11-09$15.61/sh−10,111$157,847→ 4,907 total - Sale
Common Stock
2022-11-08$16.38/sh−1,255$20,559→ 15,018 total - Sale
Common Stock
2022-11-08$15.41/sh−5,800$89,388→ 16,273 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001914503
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 8:33 PM ET
- Size
- 11.5 KB